{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T04:42:50Z","timestamp":1793421770693,"version":"4.5.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T00:00:00Z","timestamp":1733961600000},"content-version":"am","delay-in-days":346,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K12HD043446"],"award-info":[{"award-number":["K12HD043446"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30CA014236"],"award-info":[{"award-number":["P30CA014236"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014228","name":"Duke Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014228","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["americanjournalofsurgery.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Surgery"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.amjsurg.2023.10.011","type":"journal-article","created":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T20:47:22Z","timestamp":1696452442000},"page":"146-152","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["BRCA1\/2 mutation carriers &amp; risk reducing mastectomy: Who undergoes surgery and potential benefits"],"prefix":"10.1016","volume":"227","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2825-9156","authenticated-orcid":false,"given":"Sydney M.","family":"Record","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha M.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koumani","family":"Ntowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Chiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer K.","family":"Plichta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.amjsurg.2023.10.011_bib1","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1097\/GRF.0000000000000239","article-title":"Breast cancer Epidemiology and risk factors","volume":"59","author":"Rojas","year":"2016","journal-title":"Clin Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.amjsurg.2023.10.011_bib2","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.2741\/4185","article-title":"Breast cancer genes: beyond BRCA1 and BRCA2","volume":"18","author":"Filippini","year":"2013","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"23","key":"10.1016\/j.amjsurg.2023.10.011_bib3","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1056\/NEJMsr1501341","article-title":"Gene-panel sequencing and the prediction of breast-cancer risk","volume":"372","author":"Easton","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1016\/j.amjsurg.2023.10.011_bib4","doi-asserted-by":"crossref","first-page":"524","DOI":"10.3390\/cancers10120524","article-title":"BRCA mutations and breast cancer prevention","volume":"10","author":"Kotsopoulos","year":"2018","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.amjsurg.2023.10.011_bib5","first-page":"12","article-title":"Risk-reducing breast and gynecological surgery for BRCA mutation carriers: a narrative review","author":"Bertozzi","year":"2023","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.amjsurg.2023.10.011_bib6","first-page":"1","article-title":"Bilateral prophylactic mastectomy in BRCA mutation carriers: what surgeons need to know","volume":"90","author":"Franceschini","year":"2019","journal-title":"Ann Ital Chir"},{"issue":"3","key":"10.1016\/j.amjsurg.2023.10.011_bib7","doi-asserted-by":"crossref","first-page":"67","DOI":"10.4103\/ajm.AJM_21_18","article-title":"Prophylactic mastectomy for the prevention of breast cancer: review of the literature","volume":"8","author":"Alaofi","year":"2018","journal-title":"Avicenna J Med"},{"issue":"6","key":"10.1016\/j.amjsurg.2023.10.011_bib8","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1007\/s11136-015-1181-6","article-title":"Quality of life among patients after bilateral prophylactic mastectomy: a systematic review of patient-reported outcomes","volume":"25","author":"Razdan","year":"2016","journal-title":"Qual Life Res"},{"issue":"1","key":"10.1016\/j.amjsurg.2023.10.011_bib9","doi-asserted-by":"crossref","first-page":"77","DOI":"10.6004\/jnccn.2021.0001","article-title":"Genetic\/familial high-risk assessment: breast, ovarian, and pancreatic, version 2.2021, NCCN clinical practice guidelines in oncology","volume":"19","author":"Daly","year":"2021","journal-title":"J\u00a0Natl Compr Canc Netw."},{"issue":"17","key":"10.1016\/j.amjsurg.2023.10.011_bib10","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/jnci\/djj332","article-title":"Projecting absolute invasive breast cancer risk in white women with a model that includes mammographic density","volume":"98","author":"Chen","year":"2006","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"11","key":"10.1016\/j.amjsurg.2023.10.011_bib11","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1093\/jnci\/85.11.892","article-title":"The lifetime risk of developing breast cancer","volume":"85","author":"Feuer","year":"1993","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"11","key":"10.1016\/j.amjsurg.2023.10.011_bib12","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1093\/jnci\/88.11.754","article-title":"DNA repair proficiency: potential susceptiblity factor for breast cancer","volume":"88","author":"Helzlsouer","year":"1996","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.amjsurg.2023.10.011_bib13","doi-asserted-by":"crossref","unstructured":"Milne RL, Osorio A, Ram\u00f3n y Cajal T, et\u00a0al. Parity and the risk of breast and ovarian cancer in BRCA1 and BRCA2 mutation carriers. Breast Cancer Res Treat. 2010\/01\/\/2010;119(1):221-232. doi:10.1007\/s10549-009-0394-1.","DOI":"10.1007\/s10549-009-0394-1"},{"issue":"5","key":"10.1016\/j.amjsurg.2023.10.011_bib14","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/(SICI)1097-0215(19970529)71:5<800::AID-IJC18>3.0.CO;2-B","article-title":"Family history and the risk of breast cancer: a systematic review and meta-analysis","volume":"71","author":"Pharoah","year":"1997","journal-title":"Int J Cancer"},{"issue":"7","key":"10.1016\/j.amjsurg.2023.10.011_bib15","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1001\/jama.279.7.535","article-title":"Alcohol and breast cancer in women: a pooled analysis of cohort studies","volume":"279","author":"Smith-Warner","year":"1998","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.amjsurg.2023.10.011_bib16","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s10549-019-05345-2","article-title":"Survival after bilateral risk-reducing mastectomy in healthy BRCA1 and BRCA2 mutation carriers","volume":"177","author":"Heemskerk-Gerritsen","year":"2019","journal-title":"Breast Cancer Res Treat"},{"issue":"8","key":"10.1016\/j.amjsurg.2023.10.011_bib17","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1093\/annonc\/mdt134","article-title":"Substantial breast cancer risk reduction and potential survival benefit after bilateral mastectomy when compared with surveillance in healthy BRCA1 and BRCA2 mutation carriers: a prospective analysis","volume":"24","author":"Heemskerk-Gerritsen","year":"2013","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1016\/j.amjsurg.2023.10.011_bib18","article-title":"Risk-reducing mastectomy for the prevention of primary breast cancer","volume":"4","author":"Carbine","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"10.1016\/j.amjsurg.2023.10.011_bib19","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1245\/s10434-009-0641-z","article-title":"Patient and surgeon characteristics associated with increased use of contralateral prophylactic mastectomy in patients with breast cancer","volume":"16","author":"Arrington","year":"2009","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"10.1016\/j.amjsurg.2023.10.011_bib20","doi-asserted-by":"crossref","first-page":"3466","DOI":"10.1245\/s10434-014-3747-x","article-title":"Predictors that influence contralateral prophylactic mastectomy election among women with ductal carcinoma in situ who were evaluated for BRCA genetic testing","volume":"21","author":"Elsayegh","year":"2014","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"10.1016\/j.amjsurg.2023.10.011_bib21","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1158\/1940-6207.CAPR-09-0130","article-title":"Factors affecting the decision of breast cancer patients to undergo contralateral prophylactic mastectomy","volume":"3","author":"Yi","year":"2010","journal-title":"Cancer Prev Res"},{"issue":"4","key":"10.1016\/j.amjsurg.2023.10.011_bib22","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1159\/000276573","article-title":"Clinical characteristics and choices regarding risk-reducing surgery in BRCA mutation carriers","volume":"69","author":"Stuckey","year":"2010","journal-title":"Gynecol Obstet Invest"},{"issue":"4","key":"10.1016\/j.amjsurg.2023.10.011_bib23","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.amjsurg.2016.06.010","article-title":"Risk reduction and survival benefit of prophylactic surgery in BRCA mutation carriers, a systematic review","volume":"212","author":"Ludwig","year":"2016","journal-title":"Am J Surg"},{"issue":"5","key":"10.1016\/j.amjsurg.2023.10.011_bib24","first-page":"544","article-title":"Risk-reducing mastectomy","volume":"68","author":"Chiesa","year":"2016","journal-title":"Minerva Ginecol"},{"key":"10.1016\/j.amjsurg.2023.10.011_bib25","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/4317693","article-title":"Ductal carcinoma in situ (DCIS) diagnosed by MRI-guided biopsy among BRCA1\/BRCA2 mutation carriers","volume":"2022","author":"Faermann","year":"2022","journal-title":"Breast J"},{"issue":"11","key":"10.1016\/j.amjsurg.2023.10.011_bib26","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.7326\/0003-4819-127-11-199712010-00014","article-title":"Using autopsy series to estimate the disease \u201creservoir\u201d for ductal carcinoma in situ of the breast: how much more breast cancer can we find?","volume":"127","author":"Welch","year":"1997","journal-title":"Ann Intern Med"}],"container-title":["The American Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002961023005196?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002961023005196?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T11:14:18Z","timestamp":1762082058000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002961023005196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":26,"alternative-id":["S0002961023005196"],"URL":"https:\/\/doi.org\/10.1016\/j.amjsurg.2023.10.011","relation":{},"ISSN":["0002-9610"],"issn-type":[{"value":"0002-9610","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"BRCA1\/2 mutation carriers & risk reducing mastectomy: Who undergoes surgery and potential benefits","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjsurg.2023.10.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}